India's Push for API Self-Reliance Under the PLI Scheme
India’s Production Linked Incentive (PLI) scheme for bulk drugs and key starting materials is transforming the country’s pharmaceutical manufacturing landscape, pushing the sector toward self-reliance.
Key Starting Materials (KSMs) | 31/08/2025 | By Darshana | 674
India Clears 48 Projects Under PLI Scheme to Boost Domestic Production of Key Drug Ingredients
A total of 48 projects have been approved under the Production Linked Incentive (PLI) Scheme to boost domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) in India, according to the Ministry of Chemicals and Fertilizers.
Key Starting Materials (KSMs) | 23/07/2025 | By Dineshwori | 299
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy